-
Teen sprint star Gout Gout 'ready to rock and roll' in Melbourne
-
Hezbollah rejects truce talks as Israel presses Lebanon strikes
-
Mideast war fuels disinformation about Taiwan's gas supply
-
Kohli, Suryavanshi to light up IPL as stampede dead remembered
-
Moon race: how China is challenging the US
-
Zimbabwe lithium export ban triggers crackdown, concerns
-
Embiid, George make triumphant NBA returns in Sixers win
-
North Korea's Kim 'warmly' welcomes Belarusian leader
-
Oil edges up and equities mixed amid mixed messages on 'talks'
-
Russian oil arrives as Philippines battles 'energy emergency'
-
G7 meets in France to narrow transatlantic Iran split
-
WTO mulls future of global trade under cloud of Mideast war
-
Former Australian Rules player first to come out as gay
-
McKellar tells Waratahs to 'roll sleeves up' against rivals Brumbies
-
Iran says 'no negotiations' as US warns to accept 15-point deal
-
Postecoglou 'not done yet' as he watches Spurs and Forest battle relegation
-
US activists work to connect Iranians via Starlink
-
MLS dreams of global fanbase after World Cup showcase
-
Sabalenka and Rybakina to clash again in Miami semi-final
-
Former Australian Rules player is first to come out as openly gay
-
London plans two-day mega 100,000-runner marathon
-
UN pushes fuel solution for Cuba aid work amid US talks
-
Belarus' Lukashenko greeted by North Korean leader in Pyongyang
-
Video shows Chiefs star Mahomes making progress in NFL comeback
-
Bayern beat Man Utd in five-goal women's Champions League thriller
-
Wales would be 'massive asset' to World Cup, says Bellamy
-
NFL champion Seahawks to open season on September 9
-
Silver vows NBA tanking solution before draft, seeks Euroleague partnership
-
Day of reckoning arrives for social media after US court loss
-
World Cup concerns are exaggerated, says FIFA vice-president
-
Oil prices slip, stocks rally as Washington, Tehran bicker over talks
-
NBA team owners approve exploring expansion to Seattle and Las Vegas
-
UK teenagers to trial social media bans, digital curfews
-
World champions England still 'unfinished' ahead of Six Nations, says Mitchell
-
Rybakina outlasts Pegula to reach Miami Open semis
-
Barca build huge lead on Real Madrid in Women's Champions League quarters
-
Alleged Rihanna mansion shooter pleads not guilty
-
US jury finds Meta, YouTube liable in social media addiction trial
-
US says Iran talks continue, will 'unleash hell' if no deal
-
UN designates African slave trade as 'gravest crime against humanity'
-
Trump's Beijing trip rescheduled for May, after Iran delay
-
No more excuses: World Cup pressure is on for host USA
-
US EPA issues waiver for E15 fuel to address oil supply issues
-
Grieving families hail court victory against Instagram, YouTube
-
Internet providers not liable for music piracy by users: top US court
-
Gaza civil defence says Israeli strike kills one, tents on fire
-
UK govt denies cover-up after PM ex-aide's phone stolen
-
California jury finds Meta, YouTube liable in social media addiction trial
-
Oil prices slip, stocks rally on Mideast peace hopes
-
South Africa police clash with anti-immigrant protesters
US greenlights pig kidney transplant trials
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.
Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.
United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.
The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.
The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.
Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.
"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.
Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.
Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.
Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.
United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.
Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.
She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.
G.AbuGhazaleh--SF-PST